{"product_id":"scripps-md-anderson-cancer-center-33rd-annual-cutaneous-malignancy-update-melanoma-2023","title":"Scripps MD Anderson Cancer Center 33rd Annual Cutaneous Malignancy Update Melanoma 2023","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003csection class=\"component component--paragraph omega\" data-columns=\"12\" data-component-behavior-id=\"cdd72c3a62d5f18d8cb3\" data-uuid=\"Event-82115-faf4adc491\" id=\"component_faf4adc491\"\u003e\n\u003cdiv class=\"component-content\"\u003e\n\u003cdiv class=\"component-title\"\u003e\u003cheader data-context-name=\"title\"\u003e\n\u003ch3 class=\"linked-title--section\"\u003eConference Overview\u003c\/h3\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003cdiv class=\"component-text wysiwyg-content\" data-context-name=\"text\"\u003e\n\u003cbr\u003e\u003cbr\u003eScripps MD Anderson Cancer Center 33rd Annual Cutaneous Malignancy Update Melanoma 2023 As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases.\u003cbr\u003e\u003cbr\u003eDuring this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems.\u003cbr\u003e\u003ch5\u003eThe course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.\u003c\/h5\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003csection class=\"component component--paragraph omega\" data-columns=\"12\" data-component-behavior-id=\"71943300bd3767a4cbbf\" data-uuid=\"Event-82115-cfc2f5a8d5\" id=\"component_cfc2f5a8d5\"\u003e\n\u003cdiv class=\"component-content\"\u003e\n\u003cdiv class=\"component-title\"\u003e\u003cheader data-context-name=\"title\"\u003e\n\u003ch3 class=\"linked-title--section\"\u003eEducational Objectives\u003c\/h3\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003cdiv class=\"component-text wysiwyg-content\" data-context-name=\"text\"\u003e\n\u003cstrong\u003eAfter attending this live activity, participants should be able to:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDemonstrate how newly discovered, evidence-based scientific information applies to the current practice of clinical dermatology.\u003c\/li\u003e\n\u003cli\u003eDescribe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.\u003c\/li\u003e\n\u003cli\u003eExamine current data and new strategies for the prevention of melanoma.\u003c\/li\u003e\n\u003cli\u003eRelate case studies to other healthcare professionals to improve patient care.\u003c\/li\u003e\n\u003cli\u003eEvaluate and diagnose a variety of malignancies related to melanoma skin cancer.\u003c\/li\u003e\n\u003cli\u003eIdentify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.\u003c\/li\u003e\n\u003cli\u003eIncorporate new diagnostic techniques, including dermoscopy, into practice.\u003c\/li\u003e\n\u003cli\u003eDetermine appropriate treatment for patients with metastatic melanoma, melanonychia and ocular melanoma.\u003c\/li\u003e\n\u003cli\u003eIntegrate new therapies and treatments for advanced melanoma including surgical techniques.\u003c\/li\u003e\n\u003cli\u003eDiscuss the effectiveness of neoadjuvant therapy and immunotherapy in treating melanoma.\u003c\/li\u003e\n\u003cli\u003eNavigate the medico-legal aspects of caring for the melanoma patient.\u003c\/li\u003e\n\u003cli\u003eRecommend strategies for managing patients with multiple melanomas.\u003c\/li\u003e\n\u003cli\u003eProvide optimal follow-up of patients after melanoma treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch3\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eDermatologists\u003c\/li\u003e\n\u003cli\u003ePathologists\u003c\/li\u003e\n\u003cli\u003eDermatopathologists\u003c\/li\u003e\n\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\n\u003cli\u003eDermatology Nurses\/Nurse Practitioners\/Physician Assistants\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCutaneous Toxicities of Immune Therapy- Aleksandr Itkin, MD.mp4\u003cbr\u003eDermoscopy and New Diagnostic Techniques- Travis Blalock, MD.mp4\u003cbr\u003eDysplastic Nevi – Ben Kelley, MD.mp4\u003cbr\u003eEvaluation of Melanonychia- Frederick Fish, MD.mp4\u003cbr\u003eEvaluation of the Melanoma Patient for Other Primary Melanoma Lesions- Frederick Fish, MD.mp4\u003cbr\u003eMelanoma in the Molecular Age Part 1- New Tools for Diagnosis, Prognosis- Gregory Hosler, MD, PhD.mp4\u003cbr\u003eMelanoma in the Molecular Age Part 2- New Tools for Diagnosis, Prognosis- Gregory Hosler, MD, PhD.mp4\u003cbr\u003eMelanoma, the Primary Lesion- Biopsy, Excision and Mohs Surgery in Selected Cases- David Kent, MD.mp4\u003cbr\u003eMelanoma- Art and Science, Yesterday and Today – James Patterson, MD.mp4\u003cbr\u003eMelanoma- Head and Neck Surgeon’s Perspective- Brendan Gaylis, MD.mp4\u003cbr\u003eMelanoma- Medical Legal Complications- Robert Cosgrove, ESQ.mp4\u003cbr\u003eMetastatic Evaluation of the Melanoma Patient- Surget Cox, MD.mp4\u003cbr\u003eMinistering to the Melanoma Patient- Reverend Jack Baca.mp4\u003cbr\u003eNeoadjuvant Therapy for Advanced Resectable Melanoma- Merrick Ross, MD.mp4\u003cbr\u003eOcular and Periocular Melanoma- Geva Mannor, MD.mp4\u003cbr\u003eOncolytic Immunotherapy- Merrick Ross, MD.mp4\u003cbr\u003ePathology of Melanoma- Current Status and Prognostic Indicators- Cora Humberson, MD.mp4\u003cbr\u003eRadiation Therapy for Melanoma Including Lentigo Maligna- Prabhakar Tripuraneni, MD.mp4\u003cbr\u003eSaturday, January 21, 2023- Afternoon Case Presentations.mp4\u003cbr\u003eSaturday, January 21, 2023- Morning Case Presentations.mp4\u003cbr\u003eSentinel Node Evaluation- Merrick Ross, MD.mp4\u003cbr\u003eSunday Morning Case Presentations.mp4\u003cbr\u003eThe Role of UV Radiation and Exposure in Melanoma- David Kent, MD.mp4\u003cbr\u003eTreatment of Advanced Melanoma- Kathryn Bollin, MD.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954428743778,"sku":"MED-AMB03297","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-MD-Anderson-Cancer-Center-33rd-Annual-Cutaneous-Malignancy-Update-Melanoma-2023.png?v=1779376473","url":"https:\/\/meducourse.com\/products\/scripps-md-anderson-cancer-center-33rd-annual-cutaneous-malignancy-update-melanoma-2023","provider":"Meducourse","version":"1.0","type":"link"}